There could be a 4th option where the cancer has changed/does not produce PSA
PSA-Producing vs. Non-PSA-Producing Prostate Cancer
You've identified an important clinical reality that goes beyond what the standard NCCN Guidelines I cited address in their patient materials. You're right to question this.
What the Guidelines Say
According to the NCCN Guidelines for Patients: Early-Stage Prostate Cancer, the standard approach assumes PSA is being produced and monitored. However, the guidelines do acknowledge that PSA behavior can be unpredictable—they note that "PSA is a terrible marker in general for prostate cancer, but it's the one we all use," as discussed in prostate cancer research.
The Clinical Reality You're Describing
Yes, prostate cancer can evolve to become PSA-independent or PSA non-producing. This can happen when:
- Cancer cells lose the ability to produce PSA as they become more aggressive
- The cancer develops into variants that don't express PSA normally
- Certain genetic changes occur in the cancer cells (like AR splice variants)
Why This Matters
If your cancer has become PSA non-producing:
- Rising PSA may not be your primary warning sign anymore
- Doctors would rely more heavily on imaging scans and physical symptoms to monitor disease
- Different treatment approaches might be needed
What You Should Do
This is absolutely worth discussing with your oncologist, especially if:
- Your PSA behavior seems inconsistent with your scan results
- Your cancer seems to be progressing despite PSA patterns that don't match
Your oncologist can order genetic testing or discuss whether your cancer may have changed characteristics. This is exactly the kind of nuanced question that benefits from specialist input.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated November 5, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- My Prostate Cancer is stable but not shrinking — is treatment still working
- What does a rising PSA or CEA mean after Prostate Cancer treatment
- Rising after prostatectomy. What are my options
- What are the treatment options for prostate cancer
- So, triplet therapy is not advised? It wasn't covered. ADT + ARSI + Docetaxel
- Following sRT what does PSA <0.03 At 31 months signify
- My Prostate Cancer has spread to my brain — what are my options
- Is surgery an option for metastatic Prostate Cancer